Tequin

Active Ingredient(s): Gatifloxacin
FDA Approved: * December 17, 1999
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Tequin Overview

Gatifloxacin (INN; brand names Gatiflo, Tequin, and Zymar) is an antibiotic of the fourth-generation fluoroquinolone family,[1] that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced gatifloxacin in 1999 under the proprietary name Tequin for the treatment of respiratory tract infections, having licensed the medication from Kyorin Pharmaceutical Company of Japan. Allergan produces it in eye-drop fo...

Read more Tequin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Gatifloxacin

Recent Tequin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Gatifloxacin

Injection: 10mg/ml, 200mg/100ml(2mg/ml), 2mg/ml, 400mg/200ml(2mg/ml), 400mg/40ml(10mg/ml), eq 10mg /ml(200mg)
Powder for Reconstitution: 200mg/5ml
Solution: 0.3%, 0.30%, 0.5%
Solution/drops: 0.3%, 0.30%, 0.5%, 0.50%
Suspension: 200mg/5ml
Tablet: 200mg, 400mg

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Tequin

Tequin Overview

Recent Tequin Forums:

Possible Dosages for this and Related Drugs:

Other drugs which contain Gatifloxacin or a similar ingredient: (3 results)

Related Tequin Topics: